Immune responses to a single dose of the AZD1222/Covishield vaccine at 16 weeks in individuals in Sri Lanka

<p>Due to limited access to vaccines, many countries have only administered a single dose of the AZD1222, whereas the dosage intervals have increased ≥4 wk. We sought to investigate the immunogenicity of a single dose of vaccine at ≥16 wk postimmunization. Severe acute respirator...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Jeewandara, C, Guruge, D, Pushpakumara, PD, Kamaladasa, A, Aberathna, IS, Ramu, ST, Gunasekera, B, Wijesinghe, A, Dissanayake, O, Kuruppu, H, Ranasinghe, T, Jayathilaka, D, Dayarathna, S, Ekanayake, D, Jayamali, J, Gamalath, N, Mudunkotiwa, A, Somathilake, G, Dissanayake, M, Harvie, M, Nimasha, T, Madusanka, D, Jayadas, T, Wijayamuni, R, Schimanski, L, Rijal, P, Tan, TK, Townsend, A, Ogg, GS, Malavige, GN
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	American Association of Immunologists 2021

Immune responses to a single dose of the AZD1222/Covishield vaccine at 16 weeks in individuals in Sri Lanka

Antzeko izenburuak